Loading...
Loading...
Trademark Dashboard – UK Trademark Search & ClearanceApplication UK00914196331 · Registered
| Application Number | UK00914196331 |
| Status | Registered |
| Owner | STADA Arzneimittel AG |
| Filed | 2015-06-05 |
| Registered | 2015-10-14 |
| Renewal Due | 2035-06-05 |
| Type | Individual |
| Feature | Word |
| Attorney | See claim section below |
Yes. INDENZIQ is currently a registered UK trademark, with renewal due on 2035-06-05. It is protected under UK intellectual property law and can be enforced against infringing uses.
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Pharmaceutical preparations; Veterinary preparations; Sanitary preparations for medical purposes; Dietary supplements and dietetic preparations; Dietary supplements for humans; Dietary supplements for animals; Medical and veterinary preparations and articles; Infant formula; Diagnostic preparations; Plasters, materials for dressings; Dressings, medical; Teeth filling material; Dental impression materials; Disinfectants; Preparations for destroying vermin; Fungicides; Herbicides.
Surgical instruments; Medical and veterinary apparatus and instruments; Dental apparatus and instruments; Medical instruments for application on animal bodies; Applicators for medications; Medical apparatus for introducing pharmaceutical preparations into the human body; Diagnostic apparatus for medical purposes; Artificial limbs; Artificial eyes; Artificial teeth; Orthopedic articles.
Medical services; Providing of medical information relating to diseases and health problems, including online and on the internet; Dissemination of medical information via an interactive platform.
'INDENZIQ' is a registered trademark on the UK IPO register, owned by STADA Arzneimittel AG. The application (UK00914196331) was filed on 5 June 2015 and registered on 14 October 2015. The registration is set to expire on 5 June 2035.
This mark is recorded under multiple classes: Class 5 (pharmaceuticals & medical preparations); Class 10 (medical & surgical apparatus); Class 44 (medical, veterinary & beauty services).
The trademark is represented by Potter Clarkson LLP.
UK trademark UK00914196331 for the mark 'INDENZIQ' in Class 5, 10, 44 is recorded on the UK IPO register as owned by STADA Arzneimittel AG. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
Yes — the UK IPO records UK trademark UK00914196331 for the mark 'INDENZIQ' as registered.
UK trademark UK00914196331 for the mark 'INDENZIQ' is recorded in Class 5 (pharmaceuticals & medical preparations); Class 10 (medical & surgical apparatus); Class 44 (medical, veterinary & beauty services). The filed specification reads: Class 5: Pharmaceutical preparations; Veterinary preparations; Sanitary preparations for medical purposes; Dietary supplements and dietetic preparations; Dietary supplements for humans; Dietary supplements for animals; Medical and veterinary preparations and articles; Infant formula; Diagnostic preparations; Plaster…
UK trademark UK00914196331 for the mark 'INDENZIQ' was filed at the UK IPO on 5 June 2015 and registered on 14 October 2015.
UK trademark UK00914196331 for the mark 'INDENZIQ' is currently recorded as valid until 5 June 2035, at which point it will need to be renewed with the UK IPO to remain in force.
Potter Clarkson LLP is listed as the attorney / representative of record for UK trademark UK00914196331 for the mark 'INDENZIQ' on the UK IPO register.
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.